Brief: Sigilon Therapeutics Posts Q3 Loss Per Share Of $0.63
Nov 10 (Reuters) - Sigilon Therapeutics Inc SGTX.O :
* SIGILON THERAPEUTICS REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS AND BUSINESS HIGHLIGHTS
* QTRLY LOSS PER SHARE $0.63
* Q3 EARNINGS PER SHARE VIEW $-0.66 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX3Y62l3
Further company coverage: SGTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sigilon Therapeutics
See all newsSigilon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Sigilon Therapeutics Inc expected to post a loss of $4.71 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Micron, Greenbrier, Immunome
Sigilon jumps on Eli Lilly's buyout deal to expand diabetes treatments
U.S. STOCKS ON THE MOVE-Sigilon, Netflix, RenovoRx